T2 Biosystems, Inc.: T2 Biosystems Announces First Quarter 2023 Financial Results

LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today

Related Keywords

,John Sperzel ,Gewinn Nur ,Resistance Panel ,Biosystems Inc ,Cauris Panel ,Nasdaq ,While The Company ,Biothreat Panel ,Gilmartin Group ,Exchange Commission ,Lyme Panel ,Company Annual Report On Form ,Device Designation ,Medical Affairs ,Conference Call ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Trip Taylor ,Kbiosystems ,Nnounces ,First ,Quarter ,023 ,Financial ,Results ,